Evidence map›Paper›PMID 37506331›Full record

ReviewAnnual review of pharmacology and toxicology2024

High-Throughput Screening to Advance In Vitro Toxicology: Accomplishments, Challenges, and Future Directions.

Caitlin Lynch, Srilatha Sakamuru, Masato Ooka, Ruili Huang, Carleen Klumpp-Thomas, Paul Shinn, David Gerhold, Anna Rossoshek, Sam Michael, Warren Casey and 5 more

Open access · hybridAbstract readReview
In one paragraph

Review in Annual review of pharmacology and toxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 43 citations in OpenAlex.

  1. A Hybrid Experimental and in silico Platform for ITPK1 Chemical Probe Discovery.SLAS discovery : advancing life sciences R & D · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Current approaches and advances in placental toxicology.Trends in endocrinology and metabolism: TEM · 2026
    Review
  12. Article
  13. Frontiers in veterinary science · 2026
    Review
  14. Article
  15. Emerging advances in intestinal models for in vitro preclinical research.American journal of physiology. Gastrointestinal and liver physiology · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. Machine Learning-Enabled Drug-Induced Toxicity Prediction.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Caitlin LynchNational Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA; email: Caitlin.Lynch@nih.gov, mxia@mail.nih.gov.
Srilatha SakamuruNational Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA; email: Caitlin.Lynch@nih.gov, mxia@mail.nih.gov.
Masato OokaNational Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA; email: Caitlin.Lynch@nih.gov, mxia@mail.nih.gov.
Ruili HuangNational Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA; email: Caitlin.Lynch@nih.gov, mxia@mail.nih.gov.
Carleen Klumpp-ThomasNational Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA; email: Caitlin.Lynch@nih.gov, mxia@mail.nih.gov.
Paul ShinnNational Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA; email: Caitlin.Lynch@nih.gov, mxia@mail.nih.gov.
David GerholdNational Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA; email: Caitlin.Lynch@nih.gov, mxia@mail.nih.gov.
Anna RossoshekNational Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA; email: Caitlin.Lynch@nih.gov, mxia@mail.nih.gov.
Sam MichaelNational Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA; email: Caitlin.Lynch@nih.gov, mxia@mail.nih.gov.
Warren CaseyDivision of the National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina, USA.
Michael F SantilloDivision of Toxicology, Office of Applied Research and Safety Assessment, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, Laurel, Maryland, USA.
Suzanne FitzpatrickCenter for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, Maryland, USA.
Russell S ThomasCenter for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, USA.
Anton SimeonovNational Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA; email: Caitlin.Lynch@nih.gov, mxia@mail.nih.gov.
Menghang XiaNational Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USA; email: Caitlin.Lynch@nih.gov, mxia@mail.nih.gov.
National Institutes of Health · USNational Center for Advancing Translational Sciences · USCenter for Food Safety and Applied Nutrition · USEnvironmental Protection Agency · USUnited States Food and Drug Administration · US

Funding

Research Services Section (RSS)ZICTR000242 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI WILSON, KELLI · 2015 to 2025
$64.9M
Pathology Services Supporting the Division Translational ToxicologyZICES103376 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI CESTA, MARK · 2022 to 2025
$23.9M
ZIA CARCI Carcinogenicity Health Effects innovation Research ProgramZIAES103383 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI PANDIRI, ARUN KUMAR · 2022 to 2025
$13.0M
Toxicology in the 21st Century Program (Tox21) - Systems ToxicologyZIATR000038 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI XIA, MENGHANG · 2015 to 2025
$5.7M
Toxicology in the 21st Century Program (Tox21) - Genomic ToxicologyZIATR000039 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI GERHOLD, DAVID · 2016 to 2025
$5.1M
Toxicology in the 21st Century Program (Tox21) - Computational ToxicologyZIATR000040 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI HUANG, RUILI · 2016 to 2025
$3.5M
Intramural NIH HHS Z99 TR999999Intramural NIH HHS ZIA TR000038
6 · The paper itself

Abstract

Traditionally, chemical toxicity is determined by in vivo animal studies, which are low throughput, expensive, and sometimes fail to predict compound toxicity in humans. Due to the increasing number of chemicals in use and the high rate of drug candidate failure due to toxicity, it is imperative to develop in vitro, high-throughput screening methods to determine toxicity. The Tox21 program, a unique research consortium of federal public health agencies, was established to address and identify toxicity concerns in a high-throughput, concentration-responsive manner using a battery of in vitro assays. In this article, we review the advancements in high-throughput robotic screening methodology and informatics processes to enable the generation of toxicological data, and their impact on the field; further, we discuss the future of assessing environmental toxicity utilizing efficient and scalable methods that better represent the corresponding biological and toxicodynamic processes in humans.

Indexed as

High-Throughput Screening AssaysToxicologyAnimalsHumansautomationhigh-throughputroboticsscreeningTox21toxicology

Identifiers

PMID37506331
PMCPMC10822017
OpenAlexW4385334468

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.